Large-scale plasma proteomic profiling identifies a high-performance biomarker panel for Alzheimer's disease screening and staging.
Yuanbing JiangXiaopu ZhouFanny C IpPhilip ChanYu ChenNicole C H LaiKit CheungRonnie M N LoEstella P S TongBonnie W Y WongAndrew L T ChanVincent C T MokTimothy C Y KwokKin Y MokJohn HardyHenrik ZetterbergAmy K Y FuNancy Y IpPublished in: Alzheimer's & dementia : the journal of the Alzheimer's Association (2021)
This study comprehensively profiled the AD plasma proteome and serves as a foundation for a high-performance, blood-based test for clinical AD screening and staging.